Pharmacotherapy: Increased stroke risk associated with osteoporosis drugs

Abstract

Patients receiving certain treatments for osteoporosis could be at increased risk of fatal stroke, according to the findings of an observational cohort study published in Osteoporosis International. the risk of death within 30 days of a diagnosis of stroke was found to rise with increasing doses of the bisphosphonates alendronate and etidronate. By contrast… (More)
DOI: 10.1038/nrendo.2010.110

Topics

Cite this paper

@article{Diaz2010PharmacotherapyIS, title={Pharmacotherapy: Increased stroke risk associated with osteoporosis drugs}, author={Rosanne Diaz}, journal={Nature Reviews Endocrinology}, year={2010}, volume={6}, pages={472-472} }